Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of urology, gynaecology & obstetrics, gastroenterology and endocrinology. The company's research activities and products are connected by a common thread focused on the provision of tailored treatments that work on the body's own terms to enable doctors to combat numerous diseases and medical conditions. The company has gained international recognition over the last 20 years for the creation of innovative medications that have improved the quality of life of children and adults from all around the world. In recent years, Ferring has expanded beyond its traditional European base. It now has offices in over 40 countries employing over 2,700 people, and its treatments are available in more than 70 countries. This expansion has allowed Ferring to maintain a double digit annual growth rate over the last two decades. Ferring's R&D projects complement Ferring's product portfolio and will add a new generation of products to some of the company's most successful specialty brands. Ferring is committed to a future where it will continue to provide new and innovative medicines by utilising existing and acquired skills and the development of pioneering technologies and, where necessary, through partnerships with academic institutes and other companies.
|
